The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma
Official Title: A Phase III Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus Physician's Choice Including Interleukin-2 and/or Dacarbazine/Temozolomide-based Therapy and/or Complete Tumor Resection in Stage IV Melanoma
Study ID: NCT00039000
Brief Summary: The primary goal of this study is to determine if people with metastatic melanoma who receive Heat Shock Protein-Peptide Complex - 96 (HSPPC-96 or Oncophage) after surgery live longer than people who may or may not have surgery but who receive conventional chemotherapy including IL-2/DTIC. A second goal is to determine the safety and frequency of side effects in subjects who receive therapy with HSPPC-96.
Detailed Description: Primary Objective: * To determine whether subjects with stage IV melanoma randomized to HSPPC-96 have longer survival than subjects randomized to physician's choice including interleukin-2 and/or dacarbazine/temozolomide and/or complete tumor resection. Secondary Objective: * To determine frequency of adverse events in subjects randomized to HSPPC-96.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Birmingham, Alabama, United States
, Scottsdale, Arizona, United States
, Berkeley, California, United States
, Los Angeles, California, United States
, Stanford, California, United States
, Vista, California, United States
, Denver, Colorado, United States
, Farmington, Connecticut, United States
, Jacksonville, Florida, United States
, Lakeland, Florida, United States
, Miami Beach, Florida, United States
, Atlanta, Georgia, United States
, Chicago, Illinois, United States
, Park Ridge, Illinois, United States
, Kansas City, Kansas, United States
, Louisville, Kentucky, United States
, Baltimore, Maryland, United States
, Boston, Massachusetts, United States
, Robbinsdale, Minnesota, United States
, Rochester, Minnesota, United States
, Columbia, Missouri, United States
, St. Louis, Missouri, United States
, Lebanon, New Hampshire, United States
, New Brunswick, New Jersey, United States
, New York City, New York, United States
, Cincinnati, Ohio, United States
, Cleveland, Ohio, United States
, Tulsa, Oklahoma, United States
, Portland, Oregon, United States
, Philadelphia, Pennsylvania, United States
, Pittsburgh, Pennsylvania, United States
, Knoxville, Tennessee, United States
, Dallas, Texas, United States
, Houston, Texas, United States
, Madison, Wisconsin, United States
, Adelaide, , Australia
, Camperdown, , Australia
, Melbourne, , Australia
, Newcastle, , Australia
, Wentworthville, , Australia
, Budapest, , Hungary
, Debrecen, , Hungary
, Pecs, , Hungary
, Szeged, , Hungary
, Aviano, , Italy
, Genova, , Italy
, Milan, , Italy
, Rimini, , Italy
, Bialystock, , Poland
, Bydgoszcz, , Poland
, Krakow, , Poland
, Arkhangelsk, , Russian Federation
, Chelyabinsk, , Russian Federation
, Kazan, , Russian Federation
, Krasnodar, , Russian Federation
, Moscow, , Russian Federation
, Novosibirsk, , Russian Federation
, Ryazan, , Russian Federation
, Samara, , Russian Federation
, St. Petersburg, , Russian Federation
, Stavropol, , Russian Federation
, Voronezh, , Russian Federation
, Gothenburg, , Sweden
, Lund, , Sweden
, Vaxjo, , Sweden
, Dnepropetrovsk, , Ukraine
, Donetsk, , Ukraine
, Ivano-Frankovsk, , Ukraine
, Kiev, , Ukraine
, Krivoy Rog, , Ukraine
, Lviv, , Ukraine
, Odessa, , Ukraine
, Uzhgorod, , Ukraine
, Vinnitsa, , Ukraine
, Leeds, , United Kingdom
, London, , United Kingdom
, Manchester, , United Kingdom